Jazz Pharmaceuticals PE Ratio 2007-2019 | JAZZ

Current and historical p/e ratio for Jazz Pharmaceuticals (JAZZ) from 2007 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Jazz Pharmaceuticals PE ratio as of December 05, 2019 is 10.58.
Jazz Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-12-05 148.10 14.17
2019-09-30 128.14 $10.45 12.26
2019-06-30 142.56 $11.08 12.87
2019-03-31 142.95 $8.02 17.82
2018-12-31 123.96 $7.30 16.98
2018-09-30 168.13 $8.45 19.90
2018-06-30 172.30 $7.07 24.37
2018-03-31 150.99 $7.29 20.71
2017-12-31 134.65 $7.95 16.94
2017-09-30 146.25 $6.07 24.09
2017-06-30 155.50 $6.45 24.11
2017-03-31 145.13 $6.53 22.23
2016-12-31 109.03 $6.31 17.28
2016-09-30 121.48 $5.72 21.24
2016-06-30 141.31 $5.70 24.79
2016-03-31 130.55 $5.30 24.63
2015-12-31 140.56 $5.23 26.88
2015-09-30 132.81 $5.21 25.49
2015-06-30 176.07 $4.23 41.62
2015-03-31 172.79 $3.53 48.95
2014-12-31 163.73 $0.83 197.27
2014-09-30 160.56 $0.43 373.40
2014-06-30 147.01 $1.25 117.61
2014-03-31 138.68 $1.24 111.84
2013-12-31 126.56 $3.53 35.85
2013-09-30 91.97 $5.91 15.56
2013-06-30 68.73 $5.23 13.14
2013-03-31 55.91 $4.99 11.20
2012-12-31 53.25 $4.76 11.19
2012-09-30 57.00 $2.27 25.11
2012-06-30 45.01 $2.41 18.68
2012-03-31 48.47 $2.67 18.15
2011-12-31 38.63 $2.67 14.47
2011-09-30 41.50 $2.44 17.01
2011-06-30 33.35 $2.07 16.11
2011-03-31 31.85 $1.18 26.99
2010-12-31 19.68 $0.74 26.59
2010-09-30 10.73 $0.35 30.66
2010-06-30 7.83 $-0.02 0.00
2010-03-31 10.90 $0.23 47.39
2009-12-31 7.88 $-0.26 0.00
2009-09-30 8.02 $-2.47 0.00
2009-06-30 3.70 $-3.49 0.00
2009-03-31 0.89 $-5.73 0.00
2008-12-31 1.93 $-7.25 0.00
2008-09-30 4.94 $-7.74 0.00
2008-06-30 7.41 $-7.49 0.00
2008-03-31 9.02 $-10.59 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.285B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.527B 10.04
Zoetis (ZTS) United States $57.408B 34.34
Astellas Pharma (ALPMY) Japan $32.261B 16.11
Eisai (ESALY) Japan $20.266B 39.08
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.422B 20.21
Merck (MKGAF) Germany $14.921B 20.36
Neurocrine Biosciences (NBIX) United States $10.834B 511.48
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.341B 0.00
Ionis Pharmaceuticals (IONS) United States $9.028B 18.28
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Sage Therapeutics (SAGE) United States $7.761B 0.00
Catalent (CTLT) United States $7.514B 30.57
Arrowhead Pharmaceuticals (ARWR) United States $6.571B 99.51
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.986B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.881B 17.55
United Therapeutics (UTHR) United States $3.915B 0.00
FibroGen (FGEN) United States $3.860B 113.44
Taro Pharmaceutical Industries (TARO) Israel $3.635B 13.29
Nektar Therapeutics (NKTR) United States $3.423B 0.00
Evotec AG (EVTCY) Germany $3.226B 52.78
PTC Therapeutics (PTCT) United States $3.079B 0.00
Heron Therapeutics (HRTX) United States $2.396B 0.00
Xencor (XNCR) United States $2.245B 68.24
Portola Pharmaceuticals (PTLA) United States $2.163B 0.00
Zogenix (ZGNX) United States $2.046B 0.00
Tilray (TLRY) Canada $1.965B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.921B 56.84
Ironwood Pharmaceuticals (IRWD) United States $1.892B 60.33
ChemoCentryx (CCXI) United States $1.704B 0.00
USANA Health Sciences (USNA) United States $1.582B 16.89
Corcept Therapeutics (CORT) United States $1.554B 18.89
Enanta Pharmaceuticals (ENTA) United States $1.252B 28.58
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.233B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.208B 8.24
Endo (ENDP) Ireland $1.132B 2.08
ArQule (ARQL) United States $1.100B 0.00
Karyopharm Therapeutics (KPTI) United States $1.046B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.033B 0.00
Radius Health (RDUS) United States $1.009B 0.00
Aerie Pharmaceuticals (AERI) United States $0.884B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.752B 0.00
Akebia Therapeutics (AKBA) United States $0.722B 0.00
Collegium Pharmaceutical (COLL) United States $0.701B 0.00
Flexion Therapeutics (FLXN) United States $0.697B 0.00
TherapeuticsMD (TXMD) United States $0.640B 0.00
Translate Bio (TBIO) United States $0.600B 0.00
ImmunoGen (IMGN) United States $0.533B 0.00
Ardelyx (ARDX) United States $0.506B 0.00
Organogenesis Holdings (ORGO) United States $0.470B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.470B 57.00
Crinetics Pharmaceuticals (CRNX) United States $0.462B 0.00
Dermira (DERM) United States $0.450B 0.00
Concordia (CXRXF) Canada $0.444B 0.00
Molecular Templates (MTEM) United States $0.441B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Harpoon Therapeutics (HARP) United States $0.438B 0.00
DURECT (DRRX) United States $0.423B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.421B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.405B 17.45
Recro Pharma (REPH) United States $0.383B 0.00
Indivior (INVVY) United States $0.379B 1.37
Siga Technologies (SIGA) United States $0.375B 8.57
OptiNose (OPTN) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.372B 0.00
Lannett Co Inc (LCI) United States $0.357B 4.16
Innate Pharma SA (IPHYF) France $0.339B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.308B 0.00
KalVista Pharmaceuticals (KALV) United States $0.273B 0.00
Rafael Holdings (RFL) United States $0.268B 0.00
GlycoMimetics (GLYC) United States $0.248B 0.00
Calithera Biosciences (CALA) United States $0.241B 0.00
Xeris Pharmaceuticals (XERS) United States $0.238B 0.00
Jounce Therapeutics (JNCE) United States $0.235B 3.14
Matinas Biopharma Holdings (MTNB) United States $0.221B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.221B 0.00
Aquestive Therapeutics (AQST) United States $0.219B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.73
Foamix Pharmaceuticals (FOMX) Israel $0.189B 0.00
Concert Pharmaceuticals (CNCE) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.143B 0.00
IMV INC (IMV) Canada $0.141B 0.00
Redhill Biopharma (RDHL) Israel $0.140B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.137B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.120B 0.00
CannTrust Holdings (CTST) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.106B 0.00
CV Sciences (CVSI) United States $0.104B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
PolarityTE (PTE) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.32
Champions Oncology (CSBR) United States $0.076B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.076B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Capnia (SLNO) United States $0.071B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Novan (NOVN) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Natural Alternatives (NAII) United States $0.055B 13.59
Mast Therapeutics (SVRA) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
IsoRay (ISR) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.025B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
Shineco (TYHT) China $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Lipocine (LPCN) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00